Stocks · Korea
271980
KOSPI
Jeil Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER6.44x
PBR0.71x
EPS1,605 KRW
BPS14,485 KRW
ROE12.27%
Dividend yield0.00%
DPS0 KRW
Payout ratio0.00%
Returns and 52-week range
1W+4.34%
1M-4.17%
3M+1.37%
6M-25.95%
1Y-28.01%
YTD-31.63%
52W high19,290원
52W low8,810원
From 52W high-46.45%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 7,222억 | -135억 | -150억 | -1.9% |
| 2023 | 7,264억 | 87억 | 52억 | 1.2% |
| 2024 | 7,045억 | -189억 | -301억 | -2.7% |
| 2025 | 5,672억 | 207억 | 320억 | 3.6% |
| Quarterly | ||||
| 2024 4Q | 1,866억 | 24억 | 62억 | 1.3% |
| 2025 1Q | 1,630억 | 57억 | 36억 | 3.5% |
| 2025 2Q | 1,376억 | 47억 | 30억 | 3.4% |
| 2025 3Q | 1,348억 | 98억 | 159억 | 7.3% |
| 2025 4Q | 1,318억 | 5억 | 95억 | 0.4% |
| 2026 1Q | 1,303억 | 4억 | 32억 | 0.3% |
Company
Address: 서울특별시 서초구 사평대로 343 제일약품 사옥
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-18[기재정정]분기보고서 (2026.03)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-16사업보고서 (2025.12)
- 2026-02-25주요사항보고서(자기주식처분결정) Major
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.